Are payers treating orphan drugs differently?

• Váldodahkkit: Joshua P. Cohen (Dahkki), Abigail Felix (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Taylor & Francis Group, 2014-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: Some orphan drugs can cost hundreds of thousands of dollars annually per patient. As a result, payer sensitivity to the cost of orphan drugs is rising, particularly in light of increased numbers of new launches in recent years. In this article, we examine payer coverage in the United Sta...